PEGEX
Price
$21.39
Change
-$0.10 (-0.47%)
Updated
Sep 20 closing price
RPMGX
Price
$109.07
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

PEGEX vs RPMGX

Header iconPEGEX vs RPMGX Comparison
Open Charts PEGEX vs RPMGXBanner chart's image
PGIM Jennison Mid-Cap Growth R2
Price$21.39
Change-$0.10 (-0.47%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PEGEX vs RPMGX Comparison Chart
Loading...
VS
PEGEX vs. RPMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEGEX is a Buy and RPMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. PEGEX (2.48B). RPMGX pays higher dividends than PEGEX: RPMGX (0.05) vs PEGEX (0.00). PEGEX was incepted earlier than RPMGX: PEGEX (7 years) vs RPMGX (32 years). PEGEX is a more actively managed with annual turnover of: 38.00 vs. RPMGX (21.70). PEGEX has a lower initial minimum investment than RPMGX: PEGEX (0) vs RPMGX (2500). RPMGX (14.65) and PEGEX (14.57) have marching annual gain over last year. RPMGX return over 5 years is better than : 14.51 vs. PEGEX (-35.96).
PEGEXRPMGXPEGEX / RPMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years32 years-
Gain YTD6.5249.02672%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets2.48B31.4B8%
Annual Yield % from dividends0.000.05-
Returns for 1 year14.5714.6599%
Returns for 3 years-27.86-13.81202%
Returns for 5 years-35.9614.51-248%
Returns for 10 yearsN/A43.29-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEAD6.90-0.10
-1.43%
CEA Industries
ELF112.91-1.68
-1.47%
elf Beauty
WAFD35.21-1.20
-3.30%
WaFd
PKST15.04-0.67
-4.26%
Peakstone Realty Trust
CHRS1.02-0.11
-9.73%
Coherus BioSciences